News
03-19-2018, 07:20 PM
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5 years survival rate of about 5-10%. Immunotherapy has recently improved survival in metastatic breast cancer patients with breast cancer harboring the expression of HER 2 receptor.
More... (https://www.news-medical.net/news/20180319/Treating-metastatic-breast-cancer-with-immunotherapy.aspx)
More... (https://www.news-medical.net/news/20180319/Treating-metastatic-breast-cancer-with-immunotherapy.aspx)